| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |


From the UNMC Eppley Cancer Center,*
University of
Nebraska Medical Center, Omaha, Nebraska; the Department of Surgery
II,
Kumamoto University School of Medicine,
Kumamoto, Japan; the Department of Visceral and Transplantation
Surgery,
Insel Hospital, Bern, Switzerland;
the Department of Surgery,§
Rheinische
Friedrich-Wilhelms-University, Bonn, Germany; and the
Departments of Biochemistry and Molecular
Biology¶
and Microbiology,||
University of Nebraska Medical Center, Omaha, Nebraska
Giant cell carcinoma of the pancreas is a rare tumor. Its histogenesis is still controversial. In a Syrian hamster pancreatic cancer model, tumors similar to human giant cell carcinomas have been induced at an extremely low rate of incidence and after the use of high doses of pancreatic carcinogens. Thus far no tumors of giant cell type have been induced by the in vitro treatment of hamster pancreatic ductal cells with the potent pancreatic carcinogen N-nitrosobis(2-oxopropyl)amine (BOP). In the present study we report the induction of giant cell carcinoma from hamster islets treated with BOP in vitro. The results suggest that in hamsters some component of islet cells, probably stem cells, are the origin of giant cell carcinoma.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |